Flash Player 9.0.0 is required for the Video Gallery.
Get Adobe Flash Player.
This retrospective multi-center study describes infusion reactions (IRs) associated with rapid infliximab infusion over 60 minutes in children with IBD. A total of 4120 rapid infusions for 453 children (median age 16 years (IQR 13.8-17.8), 289 boys, 374 with Crohn’s disease) were included. 135 patients (29.8%) received IFX rapid infusion from starting IFX while the rest received rapid IFX infusion after a median of 5 (IQR 4 – 9) standard infusions over 2 hours. 21 participants (4.6 %) had IRs with rapid infusions. In children with IBD, rapid IFX infusion 60 minutes is safe and well-tolerated.
Ms. Bibiana Martinez and Dr. Francis Dailey from Cedars-Sinai Medical Center present an IBD LIVE video abstract detailing their research that used social media data to examine IBD patients’ understanding of the risks and benefits associated with biologic therapies and how this affects decision-making.
The links below provide social media education, support and IBD Community interactions.
Colleague's E-mail is Invalid
Your message has been successfully sent to your colleague.